AT1 receptor-mediated nuclear translocation of Raf-1 in brain neurons

被引:0
|
作者
Lu, D [1 ]
Yang, H [1 ]
Raizada, MK [1 ]
机构
[1] Univ Florida, Coll Med, Dept Physiol, Gainesville, FL 32610 USA
关键词
neurons; angiotensin II; AT(1) receptor; Raf-1; neuromodulation; nuclear translocation; nuclear localization sequence; nucleolus;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin II (Ang II) interacts with the neuronal AT(1) receptor subtype and initiates a cascade of signaling events involving activation of Ras-Raf-1-MAP kinase. Raf-1-dependent activation of mitogen-activated protein kinase (MAPK) is the key in the chronic norepinephrine neuromodulatory actions of Ang II and is associated with the translocation of MAPK into the nucleus. In view of these observations, this study was designed to determine if Ang II causes cellular redistribution of Raf-1 in neuronal cells. Most of Raf-1 was localized in the cytoplasmic compartment in neurons. Ang II treatment resulted in a time-dependent increase in the translocation of immunoreactive Raf-1 from the cytoplasm into the nucleus. A fourfold increase was observed in 15 min. The nuclear sequestration of Raf-1 was blocked by losartan, an AT(1) receptor-specific antagonist, and not by PD123319, an AT(2) receptor-specific antagonist. Confocal microscopic analysis of immunofluorescence data confirmed the nuclear translocation and further showed that Raf-1 was exclusively localized into the nucleolus. These observations demonstrate, for the first time, that Ang II stimulates Raf-1 targeting into the neuronal nucleus, and they suggest that this translocation may play a direct role in the transcriptional regulation of Ang II actions.
引用
收藏
页码:424 / 427
页数:4
相关论文
共 50 条
  • [41] Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors
    Zwart, AS
    Davis, EA
    Widdop, RE
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (07) : 1429 - 1436
  • [42] Role of Raf-1 conserved region 2 in regulation of Ras-dependent Raf-1 activation
    Sendoh, H
    Hu, CD
    Wu, DM
    Song, CH
    Yamawaki-Kataoka, Y
    Kotani, J
    Okada, T
    Shima, F
    Kariya, K
    Kataoka, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (03) : 596 - 602
  • [43] Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation
    Kimoto, M
    Shirouzu, M
    Mizutani, S
    Koide, H
    Kaziro, Y
    Hirao, I
    Yokoyama, S
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (02): : 697 - 704
  • [44] Role of AT1 receptor-mediated salt retention in angiotensin II-dependent hypertension
    Crowley, Steven D.
    Zhang, Jiandong
    Herrera, Maria
    Griffiths, Robert
    Ruiz, Phillip
    Coffman, Thomas M.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 301 (05) : F1124 - F1130
  • [45] AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade
    Widdop, RE
    Matrougui, K
    Levy, BI
    Henrion, D
    HYPERTENSION, 2002, 40 (04) : 516 - 520
  • [46] Characterization of Raf-1 activation in mitosis
    Laird, AD
    Morrison, DK
    Shalloway, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) : 4430 - 4439
  • [47] Raf-1 is a binding partner of DSCR
    Cho, YJ
    Abe, M
    Kim, SY
    Sato, Y
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 439 (01) : 121 - 128
  • [48] NEW PERSPECTIVES ON RAF-1 - THE INVOLVEMENT OF P21RAS IN THE ACTIVATION OF RAF-1 AND A POTENTIAL ROLE FOR RAF-1 IN EVENTS OCCURRING LATER IN THE CELL-CYCLE
    MAMON, H
    WILLIAMS, N
    WOOD, K
    FRAZIER, AL
    LI, P
    ZMUIDZINAS, A
    KREMER, N
    DACANGELO, G
    QI, H
    SMITH, K
    FEIG, L
    PIWNICAWORMS, H
    HALEGOUA, S
    ROBERTS, T
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1991, 56 : 251 - 263
  • [49] RAF-1 IS ACTIVATED DURING MITOSIS
    LAIRD, AD
    TAYLOR, SJ
    OBERST, M
    SHALLOWAY, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) : 26742 - 26745
  • [50] Angiotensin At1 receptor signalling pathways in neurons
    Sumners, C
    Fleegal, MA
    Zhu, MY
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2002, 29 (5-6) : 483 - 490